Literature DB >> 20035715

Cooperation of NAD(P)H:quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells.

Takahito Nishiyama1, Tadashi Izawa, Mami Usami, Tomokazu Ohnuma, Kenichiro Ogura, Akira Hiratsuka.   

Abstract

Previous studies have shown that NAD(P)H:quinone oxidoreductase 1 (NQO1) plays an important role in the detoxification of menadione (2-methyl-1,4-naphthoquinone, also known as vitamin K3). However, menadiol (2-methyl-1,4-naphthalenediol) formed from menadione by NQO1-mediated reduction continues to be an unstable substance, which undergoes the reformation of menadione with concomitant formation of reactive oxygen species (ROS). Hence, we focused on the roles of phase II enzymes, with particular attention to UDP-glucuronosyltransferases (UGTs), in the detoxification process of menadione. In this study, we established an HEK293 cell line stably expressing NQO1 (HEK293/NQO1) and HEK293/NQO1 cell lines with doxycycline (DOX)-regulated expression of UGT1A6 (HEK293/NQO1/UGT1A6) and UGT1A10 (HEK293/NQO1/UGT1A10), and evaluated the role of NQO1 and UGTs against menadione-induced cytotoxicity. Our results differed from those of previous studies. HEK293/NQO1 was the most sensitive cell line to menadione cytotoxicity among cell lines established in this study. These phenomena were also observed in HEK293/NQO1/UGT1A6 and HEK293/NQO1/UGT1A10 cells in which the expression of UGT was suppressed by DOX treatment. On the contrary, HEK293/NQO1/UGT1A6 and HEK293/NQO1/UGT1A10 cells without DOX treatment were resistant to menadione-induced cytotoxicity. These results demonstrated that NQO1 is not a detoxification enzyme for menadione and that UGT-mediated glucuronidation of menadiol is the most important detoxification process. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035715     DOI: 10.1016/j.bbrc.2009.12.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

Authors:  Hayamitsu Adachi; Koichi Nakae; Shuichi Sakamoto; Chisato Nosaka; Sonoko Atsumi; Masabumi Shibuya; Nobuaki Higashi; Motowo Nakajima; Tatsuro Irimura; Yoshio Nishimura
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

2.  NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.

Authors:  Joshua P Gray; Shpetim Karandrea; Delaine Zayasbazan Burgos; Anil A Jaiswal; Emma A Heart
Journal:  Toxicol Lett       Date:  2016-08-21       Impact factor: 4.372

3.  The chemical defensome of five model teleost fish.

Authors:  Marta Eide; Xiaokang Zhang; Odd André Karlsen; Jared V Goldstone; John Stegeman; Inge Jonassen; Anders Goksøyr
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

Review 4.  NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places.

Authors:  Angel L Pey; Clare F Megarity; David J Timson
Journal:  Biosci Rep       Date:  2019-01-03       Impact factor: 3.840

5.  Association of NQO2 With UDP-Glucuronosyltransferases Reduces Menadione Toxicity in Neuroblastoma Cells.

Authors:  Monivan Chhour; Pierre Perio; Regis Gayon; Hélène Ternet-Fontebasso; Gilles Ferry; Françoise Nepveu; Jean A Boutin; Jan Sudor; Karine Reybier
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

6.  Identification and characterization of a human mitochondrial NAD kinase.

Authors:  Kazuto Ohashi; Shigeyuki Kawai; Kousaku Murata
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.